Key Market Indicators
Poland's vaccination coverage is projected to decrease, with the percentage of children aged one year old receiving vaccinations expected to drop to 80% by 2028. This marks a decline from the current 84% in 2023, averaging a 0.7-point decrease annually. This trend has been consistent since 1985, with the market seeing an average annual decline of 0.7 points. In contrast, Poland's vaccine imports are on the rise. The value of vaccine imports is anticipated to reach approximately $1.14 billion by 2028, up from $924 million in 2023. This represents an average annual growth rate of 3.2% since 1999, when the demand for vaccines has been increasing at an average rate of 2.5% per year. On the export front, Poland is also experiencing significant growth. Vaccine exports are forecasted to hit nearly $974 million by 2028, up from $766 million in 2023, reflecting a compound annual growth rate (CAGR) of 3.7%. Since 1999, Polish vaccine supply has grown at an average annual rate of 6.1%. In the global market, Poland ranked 8th in vaccine exports in 2023. India led the rankings with $766 million, followed by Belgium, the United Kingdom, and France in the second, third, and fourth positions, respectively.
